Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019




2019 Agenda at a Glance

The Phacilitate team are currently hard at work putting together the agenda for Phacilitate Leaders Europe 2019. This year, the agenda has been designed to address the 3 core challenges presented by the European advanced therapies market: investment and innovation, manufacturing and commercialisation, and patient access and healthcare. Bringing cell, gene and cellular IO into each of the tracks will facilitate the cross-pollination of these 3 modalities. 

In short, we aim to provide answers to the issues of the entire ecosystem of ATMPs, all the way from the conception of your cell and gene therapy, to introducing it to market and patient access. 

Join the advanced therapies community 

Phacilitate Leaders Europe - LinkedIn Phacilitate Leaders Europe - instagram Phacilitate Leaders Europe youtube Phacilitate Leaders Europe - Twitter
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd